159 related articles for article (PubMed ID: 17023883)
1. Viral hepatitis.
Mallat D; Schiff E
Curr Opin Gastroenterol; 2000 May; 16(3):255-61. PubMed ID: 17023883
[TBL] [Abstract][Full Text] [Related]
2. Viral hepatitis.
Amaro R; Schiff ER
Curr Opin Gastroenterol; 2001 May; 17(3):262-7. PubMed ID: 17031167
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis B: case selection and duration of therapy.
Leung N
J Gastroenterol Hepatol; 2002 Apr; 17(4):409-14. PubMed ID: 11982721
[TBL] [Abstract][Full Text] [Related]
4. Management of viral hepatitis B.
Pramoolsinsup C
J Gastroenterol Hepatol; 2002 Feb; 17 Suppl():S125-45. PubMed ID: 12000599
[TBL] [Abstract][Full Text] [Related]
5. Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Jonas S; Settmacher U; Neuhaus R; Berg T; Neuhaus P
Z Gastroenterol; 2002 Sep; 40(9):795-9. PubMed ID: 12215948
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine. A review of its therapeutic potential in chronic hepatitis B.
Jarvis B; Faulds D
Drugs; 1999 Jul; 58(1):101-41. PubMed ID: 10439933
[TBL] [Abstract][Full Text] [Related]
7. Advances in chronic viral hepatitis.
Hui AY; Sung JJ
Curr Opin Infect Dis; 2005 Oct; 18(5):400-6. PubMed ID: 16148526
[TBL] [Abstract][Full Text] [Related]
8. The impact of human immunodeficiency virus on viral hepatitis.
Mallet V; Vallet-Pichard A; Pol S
Liver Int; 2011 Jan; 31 Suppl 1():135-9. PubMed ID: 21205151
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of recurrent hepatitis B infection after liver transplantation. A retrospective analysis of 200 liver transplantations based on hepatitis B associated liver diseases].
Seehofer D; Rayes N; Bechstein WO; Naumann U; Neuhaus R; Berg T; Hopf U; Langrehr JM; Steinmüller T; Platz KP; Müller AR; Neuhaus P
Z Gastroenterol; 2000 Sep; 38(9):773-83. PubMed ID: 11072673
[TBL] [Abstract][Full Text] [Related]
10. Novel approaches to new therapies for hepatitis B virus infection.
Loomba R; Liang TJ
Antivir Ther; 2006; 11(1):1-15. PubMed ID: 16518955
[TBL] [Abstract][Full Text] [Related]
11. Management of viral hepatitis in liver transplant recipients.
Jeong SW; Choi Y; Kim JW
Clin Mol Hepatol; 2014 Dec; 20(4):338-44. PubMed ID: 25548738
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
Fontana RJ; Hann HW; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Riker-Hopkins M; Brown N;
Liver Transpl; 2001 Jun; 7(6):504-10. PubMed ID: 11443577
[TBL] [Abstract][Full Text] [Related]
13. Successful sofosbuvir-based therapy in HIV/hepatitis C virus coinfected liver transplant recipients with recurrent hepatitis C virus infection.
Grant JL; Hawkins C; Brooks H; Palella FJ; Koppe SW; Abecassis MM; Stosor V
AIDS; 2016 Jan; 30(1):93-8. PubMed ID: 26731756
[TBL] [Abstract][Full Text] [Related]
14. Update on chronic viral hepatitis.
Walsh K; Alexander GJ
Postgrad Med J; 2001 Aug; 77(910):498-505. PubMed ID: 11470928
[TBL] [Abstract][Full Text] [Related]
15. Viral hepatitis.
Marrero R; Schiff E
Curr Opin Gastroenterol; 2002 May; 18(3):330-3. PubMed ID: 17033303
[TBL] [Abstract][Full Text] [Related]
16. Management of chronic viral hepatitis before and after renal transplantation.
Gane E; Pilmore H
Transplantation; 2002 Aug; 74(4):427-37. PubMed ID: 12352899
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation.
Bain VG; Kneteman NM; Ma MM; Gutfreund K; Shapiro JA; Fischer K; Tipples G; Lee H; Jewell LD; Tyrrell DL
Transplantation; 1996 Nov; 62(10):1456-62. PubMed ID: 8958272
[TBL] [Abstract][Full Text] [Related]
18. The sequential occurrence of viral mutations in a liver transplant recipient re-infected with hepatitis B: hepatitis B immune globulin escape, famciclovir non-response, followed by lamivudine resistance resulting in graft loss.
de Man RA; Bartholomeusz AI; Niesters HG; Zondervan PE; Locarnini SA
J Hepatol; 1998 Oct; 29(4):669-75. PubMed ID: 9824278
[TBL] [Abstract][Full Text] [Related]
19. New era of liver transplantation for hepatitis B: a 17-year single-center experience.
Anselmo DM; Ghobrial RM; Jung LC; Weaver M; Cao C; Saab S; Kunder G; Chen PW; Farmer DG; Yersiz H; Baquerizo A; Geevarghese S; Han SH; Goldstein L; Holt CD; Gornbein JA; Busuttil RW
Ann Surg; 2002 May; 235(5):611-9; discussion 619-20. PubMed ID: 11981206
[TBL] [Abstract][Full Text] [Related]
20. Lamivudine therapy in patients undergoing liver transplantation for hepatitis B virus precore mutant-associated infection: high resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immune globulin.
McCaughan GW; Spencer J; Koorey D; Bowden S; Bartholomeusz A; Littlejohn M; Verran D; Chui AK; Sheil AG; Jones RM; Locarnini SA; Angus PW
Liver Transpl Surg; 1999 Nov; 5(6):512-9. PubMed ID: 10545540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
